文献速递皮肤肿瘤

胶原脯氨酰羟化酶在黑色素瘤中具有双功能生长调节作用

Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.
PubMed 文献 · J Invest Dermatol · 2018-11-16

该研究探讨了胶原脯氨酰3-羟化酶和胶原脯氨酰4-羟化酶家族在黑色素瘤中的表达、转录调控及功能。研究发现以Leprel1和Leprel2为代表的胶原脯氨酰3-羟化酶家族在原发性和转移性黑色素瘤中因甲基化依赖性转录沉默而发挥抑癌功能;而胶原脯氨酰4-羟化酶家族成员P4HA1、P4HA2和P4HA3在黑色素瘤中常过表达,其表达预示更差的临床结局。多种选择性胶原脯氨酰4-羟化酶抑制剂可减少黑色素瘤细胞的增殖并抑制侵袭性。

要点

  • Leprel1和Leprel2在黑色素瘤中因甲基化依赖性转录沉默而失活,符合抑癌功能。
  • P4HA1、P4HA2和P4HA3在黑色素瘤中常过表达,且表达预示更差的临床结局。
  • 选择性胶原脯氨酰4-羟化酶抑制剂可减少黑色素瘤细胞增殖并抑制侵袭性。

核心结论

  • 胶原脯氨酰3-羟化酶和胶原脯氨酰4-羟化酶家族可能是黑色素瘤生长和侵袭性的重要调节因子;作者认为选择性抑制胶原脯氨酰4-羟化酶是减少黑色素瘤细胞侵袭特性的有吸引力的策略。

研究设计与样本

  • 研究分析了黑色素瘤中胶原脯氨酰3-羟化酶和胶原脯氨酰4-羟化酶家族的表达、转录调控和功能,并进行了功能实验和药物抑制实验。

主要发现

  • 以Leprel1和Leprel2为代表的胶原脯氨酰3-羟化酶家族在原发性和转移性黑色素瘤中发生甲基化依赖性转录沉默,符合抑癌功能。
  • P4HA3在部分黑色素瘤中发生转录沉默,但P4HA1、P4HA2和P4HA3在黑色素瘤中常过表达,其表达预示更差的临床结局。
  • 异位表达Leprel1和Leprel2抑制黑色素瘤增殖,而P4HA2和P4HA3增加黑色素瘤细胞的增殖,尤其是侵袭性。
  • 多种选择性胶原脯氨酰4-羟化酶抑制剂可减少黑色素瘤细胞的增殖并抑制侵袭性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Appropriate post-translational processing of collagen requires prolyl hydroxylation, catalyzed by collagen prolyl 3-hydroxylase and collagen prolyl 4-hydroxylase, and is essential for normal cell function. Here we have investigated the expression, transcriptional regulation, and function of the collagen prolyl 3-hydroxylase and collagen prolyl 4-hydroxylase families in melanoma. We show that the collagen prolyl 3-hydroxylase family exemplified by Leprel1 and Leprel2 is subject to methylation-dependent transcriptional silencing in primary and metastatic melanoma consistent with a tumor suppressor function. In contrast, although there is transcriptional silencing of P4HA3 in a subset of melanomas, the collagen prolyl 4-hydroxylase family members P4HA1, P4HA2, and P4HA3 are often overexpressed in melanoma, expression being prognostic of worse clinical outcomes. Consistent with tumor suppressor function, ectopic expression of Leprel1 and Leprel2 inhibits melanoma proliferation, whereas P4HA2 and P4HA3 increase proliferation, and particularly invasiveness, of melanoma cells. Pharmacological inhibition with multiple selective collagen prolyl 4-hydroxylase inhibitors reduces proliferation and inhibits invasiveness of melanoma cells. Together, our data identify the collagen prolyl 3-hydroxylase and collagen prolyl 4-hydroxylase families as potentially important regulators of melanoma growth and invasiveness and suggest that selective inhibition of collagen prolyl 4-hydroxylase is an attractive strategy to reduce the invasive properties of melanoma cells.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Atkinson A, Renziehausen A, Wang H, et al. Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma. J Invest Dermatol. 2018. PMID: 30452903. doi:10.1016/j.jid.2018.10.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。